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Abstract
Background: Internet-based assessment has the potential to assist with the diagnosis of mental health disorders and overcome
the barriers associated with traditional services (eg, cost, stigma, distance). Further to existing online screening programs available,
there is an opportunity to deliver more comprehensive and accurate diagnostic tools to supplement the assessment and treatment
of mental health disorders.
Objective: The aim was to evaluate the diagnostic criterion validity and test-retest reliability of the electronic Psychological
Assessment System (e-PASS), an online, self-report, multidisorder, clinical assessment and referral system.
Methods: Participants were 616 adults residing in Australia, recruited online, and representing prospective e-PASS users.
Following e-PASS completion, 158 participants underwent a telephone-administered structured clinical interview and 39 participants
repeated the e-PASS within 25 days of initial completion.
Results: With structured clinical interview results serving as the gold standard, diagnostic agreement with the e-PASS varied
considerably from fair (eg, generalized anxiety disorder: κ=.37) to strong (eg, panic disorder: κ=.62). Although the e-PASS’
sensitivity also varied (0.43-0.86) the specificity was generally high (0.68-1.00). The e-PASS sensitivity generally improved
when reducing the e-PASS threshold to a subclinical result. Test-retest reliability ranged from moderate (eg, specific phobia:
κ=.54) to substantial (eg, bulimia nervosa: κ=.87).
Conclusions: The e-PASS produces reliable diagnostic results and performs generally well in excluding mental disorders,
although at the expense of sensitivity. For screening purposes, the e-PASS subclinical result generally appears better than a clinical
result as a diagnostic indicator. Further development and evaluation is needed to support the use of online diagnostic assessment
programs for mental disorders.
Trial Registration: Australian and New Zealand Clinical Trials Registry ACTRN121611000704998;
http://www.anzctr.org.au/trial_view.aspx?ID=336143 (Archived by WebCite at http://www.webcitation.org/618r3wvOG).
(J Med Internet Res 2015;17(9):e218)   doi:10.2196/jmir.4195
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Introduction
The diagnosis of mental disorders has many important roles in
clinical practice, research, and administration (eg,
communication, treatment planning and evaluation, decision
making, classification, policy development) [1]. However, there
are various issues that limit the practice and utility of diagnostic
assessment in traditional face-to-face settings [2-5]. For
example, clinicians typically favor unstructured interviewing
despite being prone to bias and error [4], whereas the more
reliable structured interviewing format is often overlooked for
being cumbersome and costly to administer in everyday practice
[5].
The Internet offers various benefits to assist the assessment of
mental disorders [6,7]. Internet-based questionnaires can
incorporate complex branching and scoring rules, as well as
seamlessly present items and feedback in a standardized manner.
The Internet also offers minimal ongoing delivery costs,
accessibility across diverse population groups, and efficient
data collection. Consumer accessibility is typically better than
for traditional face-to-face services because it is usually
associated with lower cost and greater convenience.
Furthermore, the potential anonymity of online assessment
facilitates self-awareness and self-disclosure, potentially
enabling more valid outcomes [8].
Given these advantages, numerous and diverse online diagnostic
assessment tools have been made available. However, published
psychometric properties regarding diagnostic outcomes are only
available for a small proportion of these. Furthermore,
performance varies widely across these reported programs (eg,
[9-12]), probably due to differences in program characteristics
and study methodologies. For example, Farvolden et al [9]
reported on the validity of the Web-Based Depression and
Anxiety Test (WB-DAT), a diagnostic screener for depression
and anxiety disorders that functions similarly to a structured
diagnostic interview based on Diagnostic and Statistical Manual
of Mental Disorders (Fourth Edition) (DSM-IV) criteria. With
a clinician-administered Structured Clinical Interview for
DSM-IV (SCID-IV) as the gold standard, the WB-DAT
displayed a high level of diagnostic accuracy in terms of
sensitivity (0.71-0.95) and specificity (0.87-0.97). However,
results were limited in that participants were recruited from
face-to-face clinical trials and may not have represented typical
online consumers of the program. Furthermore, the study
involved generally low diagnostic base rates that could have
biased classification statistics. Nevertheless, the results for the
WB-DAT suggest that an online program can achieve a high
level of diagnostic sensitivity and specificity.
More recently, Donker et al [10] evaluated the Web Screening
Questionnaire (WSQ), which also diagnostically screens for
multiple DSM-IV disorders (eg, depression, anxiety, and
alcohol-related disorders). Unlike the WB-DAT, the WSQ is
very brief, with only 1 to 2 items assigned to each disorder and
15 items in total to promote access and completion [10]. In
contrast to Farvolden et al’s study, participants (N=502) were
recruited online and subsequently completed the WSQ remotely
to better represent potential program usage. Compared against
a telephone-based Composite International Diagnostic Interview
(CIDI) as the gold standard, a refined version of the WSQ
displayed generally high sensitivity (0.72-1.00). However, the
WSQ demonstrated relatively poor specificity (0.44-0.77) and
low positive predictive values (PPV=0.11-0.51) with many false
positives, probably due to the small item set. Hence, although
the WSQ may be diagnostically sensitive and quick to complete,
it does so at the expense of specificity when contrasted to a
more comprehensive program such as the WB-DAT.
Within the psychometric literature of online diagnostic
programs, test-retest reliability seems to be an important, yet
underinvestigated, type of reliability given that numerous factors
(eg, changes in test-taking attitudes and lack of control in test
environment) could vary online performance and subsequent
results between sittings [13]. Only one known study has
examined the test-retest reliability of an online diagnostic
assessment tool. In Lin et al’s study, participants comprising
Taiwanese visitors to an online mental health website repeated
the Internet-based Self-assessment Program for Depression
(ISP-D), a 9- to 24-item measure of 3 different depressive
presentations [11]. The ISP-D was found to have excellent
test-retest reliability within 2 weeks (weighted κ=.80), although
performance dropped over longer durations (eg, weighted κ=.45
for 2-4 weeks). Although Lin et al’s results are promising, it is
unclear whether they can be generalized to programs targeting
other disorders and with different population groups.
Given their practical benefits and psychometric evidence,
Internet-based diagnostic assessments have been implemented
and trialed in “virtual clinics” as a means of rapid assessment
and referral to appropriate online interventions [10,14]. One
example is the electronic Psychological Assessment and
Screening System (e-PASS), which is the focus of this study.
Appearing within the Anxiety Online virtual clinic [14] (now
renamed as Mental Health Online [15]), the e-PASS
predominantly functions as a diagnostic and referral tool for
registered users and is the starting point for accessing online
treatment programs [14]. For example, a user identified by the
e-PASS as having panic disorder would be recommended to
complete an online treatment program for panic disorder [14].
Unlike many other diagnostic assessment programs, the e-PASS
aims to produce an accurate diagnostic result by incorporating
items reflecting diagnostic criteria and severity. The e-PASS
also assesses a considerably wider diagnostic breadth, including
21 DSM-IV (Text Revision; DSM-IV-TR) disorders, compared
with most publically available programs, to help accommodate
comorbid and lower prevalence disorders. Another distinct
attribute of the e-PASS is that it distinguishes the primary
diagnosis (ie, the disorder deemed of greatest severity in a
presentation) from any secondary disorders. This feature helps
users identify their main mental health issue and prioritize
treatment recommendations. Finally, the e-PASS focuses on
clinical disorders as well as “subclinical” presentations that
represent significant symptoms, but do not meet full criteria
and severity of a clinical disorder.
Preliminary evaluation has indicated high diagnostic agreement
between the e-PASS and community sources (eg, psychologist,
counselor, or medical doctor), although results were based on
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limited survey data [14]. The e-PASS has also undergone
usability testing suggesting it offers distinct benefits and
advantages (eg, convenience, anonymity, comprehensiveness)
compared to a clinician-administered interview (D Nguyen,
unpublished PhD thesis, Victoria: Swinburne University, 2013).
In particular, the e-PASS has proven to be highly accessible
with more than 22,620 completions between October 2009 and
June 2014.
As with any diagnostic assessment tool, it is crucial to formally
clarify the psychometric properties of the e-PASS. This need
is particularly apparent given the e-PASS’ high usage and
explicit role in diagnosis and treatment referral as well as
outcome measurement in a “virtual” clinic (eg, [14]). Although
psychometric evidence for several online assessment programs
exist (eg, [9,10]), their findings are limited in reflecting the
potential performance of the e-PASS. For example, the e-PASS
differs from previously examined programs in terms of
identifying a broader range of disorders (including less common
disorders such as bulimia nervosa and body dysmorphic
disorder) as well as subclinical diagnostic presentations.
Therefore, this study aimed to examine the diagnostic criterion
validity and test-retest reliability of the e-PASS involving
prospective users completing the e-PASS under relatively
naturalistic conditions. This is the first study known to the
authors to evaluate both the criterion validity and test-retest
reliability of an online multidisorder diagnostic assessment
program. This study is also distinct in examining an online
diagnostic program that is central to an internationally available
open-access “virtual” clinic for mental health disorders. The
findings will help facilitate more informed and appropriate use
of the e-PASS and further development of the e-PASS and
similar online assessment tools.
Methods
Ethical Approval
This study was approved by the Swinburne University Human
Research Ethics Committee. The study was conducted as part
of a larger trial of the Anxiety Online service, which received
trial registration with the Australian New Zealand Clinical Trials
Registry (ACTRN12611000704998) [14].
Recruitment
Recruitment targeted prospective e-PASS users. Visitors to the
Anxiety Online website who clicked a link to undertake the
e-PASS were presented a brief invitation to this research. Those
who declined proceeded with the e-PASS per usual, whereas
interested individuals were provided with an online plain
language statement and consent form. Inclusion criteria required
that individuals be 18 years of age or older and residing within
Australia (to allow for appropriate follow-up in the advent of
participation issues). All clinical populations were welcome,
although individuals experiencing acute distress or risk were
encouraged to defer participation in the e-PASS study.
Recruitment occurred between November 2009 and June 2011.
In all, 29 participants were excluded for residing outside of
Australia, leaving 616 in the total sample.
The e-PASS
The e-PASS is a comprehensive assessment program that, in
addition to diagnostic assessment, measures a range of factors
including sociodemographic background, suicide and psychosis
risk, past and current treatment, and preferred learning style.
The diagnostic component of the e-PASS consists of more than
500 items grouped into modules representing 21 DSM-IV-TR
disorders [16]: major depressive disorder (MDD), anxiety
disorders (eg, panic disorder), body dysmorphic disorder (BDD),
eating disorders (eg, bulimia nervosa), sleep disorders (eg,
primary insomnia), alcohol and substance dependence (eg,
cannabis dependence), pathological gambling, and somatization
disorder. Programmed branching rules allow users to
automatically skip nonrelevant items. As a result, users typically
only complete a subset of all diagnostic items.
Following e-PASS completion, users are presented with detailed
feedback, including a primary diagnosis (ie, the disorder rated
as most severe) and any secondary disorders identified.
Diagnostic severity is based on the extent that symptom criteria
are met and rating scores of distress and interference associated
with reported symptoms. A “clinical” diagnostic result is given
when all symptom criteria are met and rated with at least “mild”
to “moderate” distress and interference. A “subclinical” result
is assigned when some, but not all, symptom criteria are met or
when all symptom criteria are met but overall severity is rated
as less than “mild”.
Items screening for bipolar disorder and schizophrenia, as well
as the potential causal role of a medical condition, substance
use, and other notable factors (eg, bereavement in depression
symptoms) are also reflected in e-PASS diagnostic feedback
(see [14] for a more detailed account).
The Clinical Interview
The clinical diagnostic results of a clinical interview, conducted
over telephone, were considered the “gold standard.” The use
of telephone interviewing for assessing mental health disorders
has support in the literature [17-19]. Interviewers were either
fully or provisionally registered psychologists undertaking
postgraduate clinical training and were blind to participants’
e-PASS results. Two interview schedules were predominantly
used to reach a diagnosis. All interviews commenced with the
administration of the Mini International Neuropsychiatric
Interview-Plus (MINI-Plus) structured interview schedule. The
MINI-Plus is considered practical, while maintaining high
diagnostic reliability and validity with the more cumbersome,
but highly regarded, SCID-IV [20]. Participants who endorsed
MINI-Plus questions indicating some level of anxiety symptoms
were also presented the anxiety disorder modules of the Anxiety
Disorders Interview Schedule for DSM-IV-TR (ADIS-IV), a
“gold standard” semistructured interview with demonstrated
reliability [21,22]. Participants who indicated sleep difficulties
in response to a screening question were also administered the
Insomnia Severity Index, a reliable and valid instrument for
identifying clinical insomnia [23].
Procedure
Participants consented by supplying their name, email address,
and details of their general practitioner. Participants then
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completed the e-PASS, which took a mean 25.0 (SD 5.0)
minutes, and received diagnostic feedback as per usual. Between
June 2010 and June 2011, all e-PASS participants were sent an
email invitation to repeat the e-PASS within 35 days of their
initial assessment. Interviewers attempted to call participants
within 4 weeks of completing the e-PASS. Due to constraints
on the interviewing process (eg, interviewers unavailable), a
small minority of the total sample (N=616) were not contacted
and, unfortunately, it was not noted who those individuals were.
Ultimately, of the 162 participants reached, 158 agreed to
interviewing whereas 4 declined due to personal reasons.
Interviews were completed a mean of 10.4 (SD 7.0) days after
e-PASS and had a mean duration of 48.0 (SD 15.0) minutes.
Interviewers commenced with an introduction then proceeded
with administering the MINI-Plus followed by the ADIS-IV
and Insomnia Severity Index, where relevant. Interviewers were
blind to participants’ e-PASS results. Calls ended with
participants being invited to other e-PASS–related research
activities (eg, qualitative interviewing and online survey of
e-PASS experience) not reported in the present study. Following
each clinical interview, interviewers completed an assessment
summary form including diagnostic outcomes (the
presence/absence of a clinical disorder). Interviewers undertook
peer supervision and clinical supervision to discuss any clinical
concerns and diagnostic issues (eg, differential diagnoses). A
random subset of interviews were recorded for interrater
reliability testing.
Statistical Analysis
The e-PASS’ criterion validity was examined by calculating
standard classification statistics including sensitivity, specificity,
Cohen’s kappa, PPV and negative predictive values (NPV),
with diagnostic results of the clinical interview as the criterion
(ie, gold standard). Given that classification statistics can be
biased by very low diagnostic base rates, only clinical disorders
with greater than 4% prevalence according to the clinical
interview are reported. Other studies have also reported
classification statistics with similarly low base rates (eg, [9,10]).
Sensitivity reflects the proportion of people with a positive
clinical interview diagnosis who also received a positive e-PASS
diagnosis (ie, true positives). Specificity represents the
proportion of those with a negative clinical interview diagnosis
who also received a negative e-PASS diagnosis (ie, true
negatives). Sensitivity and specificity range from 0 to 1, with
higher values indicating better accuracy. Although there are no
commonly recommended thresholds for sensitivity/specificity,
a minimum sensitivity and specificity of 0.70 was considered
acceptable to reflect the priority of screening accuracy [10].
The PPV is the probability of actually having a disorder given
a positive diagnosis by the e-PASS, whereas NPV refers to the
probability of not actually having a disorder given a negative
diagnosis of the disorder by the e-PASS [24]. For sensitivity,
specificity, PPV, and NPV, 95% confidence intervals based on
the Wilson interval [25] were calculated. Confidence intervals
of these statistics reflect potential variability influenced by
diagnostic base rates (ie, wider estimates resulting from lower
base rates). It is worth noting that previous studies evaluating
similar programs (eg, [9,10]) have not included confidence
intervals.
Cohen’s kappa [26] measures diagnostic agreement beyond that
expected by chance [27]. Kappa values were interpreted
following guidelines proposed by Landis and Koch [28]:
.01-.20=slight, .21-.40=fair, .41-.60=moderate,
.61-.80=substantial, and .81-1.00=almost perfect agreement.
Kappa was also used to measure diagnostic agreement between
initial and repeated e-PASS results. The McNemar test examined
whether there were systematic changes in diagnosis from test
to retest. A significant result implies the need to reject the null
hypothesis that the clinical diagnosis for a particular disorder
has remained consistent between test and retest, and an
examination of the contingency table can then show whether
the inconsistency reflects a pattern of change from a positive to
negative or negative to positive diagnosis from test to retest
[29].
Results
Overview
The total sample comprised of 616 people, 443 (71.9%) female
and 173 (28.1%) male, with a mean age of 37.7 (SD 12.9) years.
The clinical interview sample comprised of 158 people within
the total sample. Table 1 shows the sociodemographic
characteristics of the total and clinical interview samples.
Chi-square tests found no significant differences between the
clinical interview sample and the total sample in relation to
these sociodemographic variables. A comparison in treatment
access showed that a greater proportion were currently accessing
treatment within the clinical interview sample (87/158, 55.1%)
than the total sample (290/616, 47.1%), but it was not
statistically significant (χ21=3.4, P=.06). Furthermore, results
indicated cognitive behavioral therapy access was significantly
more prevalent among the clinical interview sample (n, 21.2%)
than the total sample (n, 14.3%; χ21=6.0, P=.01).
Given so few of the clinical interview subsample (ie, 12 of 158)
were eventually recorded, it was decided not to proceed with
interrater reliability analysis.
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Table 1. Demographic variables of total sample and clinical interview subsample.
Pχ2 (df)
Clinical interview subsample,
n (%)
n=158
Total sample, n (%)
N=616Sociodemographic and treatment factors
.650.2 (1)Gender
42 (26.6)173 (28.1)Male
116 (73.4)443 (71.9)Female
.940.7 (4)Relationship
44 (27.8)175 (28.4)Married
44 (27.8)169 (27.4)Single
46 (29.1)172 (28.0)De facto
14 (8.9)66 (10.7)Separated or divorced
10 (6.3)34 (5.5)Other
.703.0 (5)Country of birth
117 (74.1)453 (73.5)Australia
14 (8.9)53 (8.6)United Kingdom
9 (5.7)30 (4.9)Asian countries
2 (1.3)22 (3.6)United States
6 (3.8)22 (3.6)European country (except UK)
10 (6.3)36 (5.8)Other
.452.6 (3)Setting
104 (65.9)384 (62.3)Metropolitan
36 (22.8)155 (25.2)Regional
13 (8.2)65 (10.6)Rural
5 (3.2)12 (1.9)Remote
.293.7 (3)Highest schooling
7 (4.4)36 (5.8)Year 9 or less
11 (7.0)70 (11.4)Year 10
12 (7.6)41 (6.7)Year 11
128 (81.0)469 (76.1)Year 12
.306.0 (5)Highest postsecondary education
17 (10.8)89 (14.4)None
15 (9.5)83 (13.4)Current undergraduate
40 (25.3)144 (23.4)Undergraduate
38 (24.1)117 (19.0)Postgraduate
22 (13.9)92 (14.9)Diploma, apprenticeship, trade
26 (16.5)91 (14.8)Certificate
.862.6 (6)Employment
65 (41.1)235 (38.1)Full time
42 (26.6)175 (28.4)Part time
10 (6.3)44 (7.1)Disability, maternity, sick leave
8 (5.1)43 (7.0)Home duties/carer
7 (4.4)19 (3.1)Retired
17 (10.8)63 (10.2)Unemployed
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Pχ2 (df)
Clinical interview subsample,
n (%)
n=158
Total sample, n (%)
N=616Sociodemographic and treatment factors
9 (5.7)37 (6.0)Other (eg volunteer, student)
.063.4 (1)87 (55.1)290 (47.1)Receiving current mental health assistance
.016.0 (1)33 (20.9)88 (14.3)Current cognitive behavior therapy access
Diagnostic Validity
Only 10 of the 21 disorders targeted by the e-PASS had
sufficient base rates to warrant meaningful classification
statistics. Among these, measures of diagnostic accuracy
indicated mixed performance (Table 2). Kappa values indicated
the e-PASS clinical diagnoses of generalized anxiety disorder
(GAD; κ=.37) and obsessive-compulsive disorder (OCD; κ=.39)
had fair agreement with the clinical interview. The remaining
disorders reflected moderate (bulimia nervosa: κ=.47) to
substantial (panic disorder: κ=.62) agreement. Sensitivity ranged
from 0.43 (alcohol dependence) to 0.86 (MDD), with half of
the disorders falling below the acceptable value of 0.70. When
taking into account confidence intervals, sensitivity estimates
ranged from as low as 0.16 (OCD, alcohol dependence) to a
maximum of 0.94 (MDD). In contrast, specificity varied between
0.68 (GAD) and 1.00 (alcohol dependence), with most values
greater than 0.90. Estimated specificity values remained
generally greater than 0.70 even after considering confidence
intervals.
The PPVs primarily varied between 0.45 (posttraumatic stress
disorder; PTSD) and 1.00 (alcohol dependence). The NPVs
were consistently higher for most disorders, with the smallest
magnitude being 0.80 (social phobia) and the remainder equal
to or greater than 0.90. From these predictive values, an e-PASS
clinical diagnosis appeared to have a low to moderate likelihood
of reflecting a positive clinical diagnosis depending on the
disorder, whereas a negative e-PASS diagnosis in general was
far more likely to be accurate.
Further analyses examined the extent to which an e-PASS
clinical or subclinical diagnostic associated with a clinical
interview clinical diagnosis. Again, only 10 disorders were
considered because of limited base rates and Table 3 summarizes
the resulting classification statistics. When considering both a
subclinical and clinical e-PASS result as a positive diagnosis,
sensitivity ranged from 0.67 (BDD) to 0.98 (MDD) and equaled
or exceeded 0.90 for 5 disorders. Specificity was generally lower
and varied between 0.38 (MDD) and 0.89 (bulimia nervosa),
with only 5 disorders considered acceptable in terms of
exceeding 0.70. Kappa values of the e-PASS subclinical/clinical
diagnoses remained significant (P<.001) and ranged from .18
(PTSD) to .47 (panic disorder, social phobia), with most
considered fair (ie, .20-.40) in diagnostic agreement with a
clinical interview clinical diagnosis.
The PPVs were generally smaller than those seen when
classification was based on the e-PASS clinical diagnosis alone.
Only panic disorder and social phobia maintained moderate
PPVs with values of 0.48 and 0.58, respectively. As a result of
the lower threshold for a positive e-PASS diagnostic result (ie,
subclinical rather than clinical diagnosis), the NPVs accordingly
increased for all the disorders, with the majority greater than
0.95. This indicates that an individual with the absence of a
relevant clinical disorder is very unlikely to receive a positive
e-PASS subclinical or clinical diagnosis for that disorder.
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Table 2. Classification statistics of e-PASS clinical diagnoses against clinical interview clinical diagnoses (n=158).
NPV (95% CI)PPV (95% CI)Specificity (95% CI)Sensitivity (95% CI)κa
Clinical inter-
view, ne-PASS diagnosis
NoYes
0.92 (0.86-0.95)0.69 (0.53-0.82)0.91 (0.85-0.95)0.71 (0.55-0.84).62Panic disorder
1125Yes
11210No
0.90 (0.82-0.95)0.45 (0.34-0.57)0.68 (0.59-0.76)0.78 (0.62-0.88).37GAD
3831Yes
809No
0.80 (0.72-0.86)0.77 (0.63-0.87)0.90 (0.84-0.96)0.60 (0.47-0.71).52Social phobia
1034Yes
9123No
0.98 (0.94-0.99)0.45 (0.26-0.66)0.92 (0.87-0.96)0.75 (0.47-0.91).52PTSD
119Yes
1353No
0.94 (0.89-0.97)0.56 (0.27-0.81)0.97 (0.93-0.99)0.36 (0.16-0.61).39OCD
45Yes
1409No
0.94 (0.87-0.97)0.61 (0.46-0.76)0.79 (0.71-0.85)0.86 (0.73-0.94).58MDD
2438Yes
906No
0.93 (0.86-0.96)0.56 (0.42-0.69)0.82 (0.74-0.88)0.78 (0.62-0.88).53Insomnia
2228Yes
1008No
0.97 (0.94-1.00)0.47 (0.26-0.69)0.94 (0.89-0.97)0.67 (0.39-0.86).51BDD
98Yes
1374No
0.97 (0.93-0.99)0.50 (0.24-0.76)0.97 (0.92-0.99)0.50 (0.24-0.76).47Bulimia nervosa
55Yes
1435No
0.97 (0.94-0.99)1.00 (0.44-1.00)1.00 (0.98-1.00)0.43 (0.16-0.75).59Alcohol dependence
03Yes
1514No
a All kappa values P<.001.
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Table 3. Classification statistics of the e-PASS subclinical or clinical diagnoses against clinical interview clinical diagnoses (n=158).
NPV (95% CI)PPV (95% CI)Specificity (95% CI)Sensitivity (95% CI)κa
Clinical inter-
view, ne-PASS diagnosis
NoYes
0.96 (0.89-0.98)0.48 (0.36-0.60)0.72 (0.64-0.79)0.89 (0.74-0.95).47Panic disorder
3431Yes
894No
0.94 (0.84-0.98)0.34 (0.26-0.44)0.40 (0.31-0.49)0.92 (0.88-0.97).21GAD
7137Yes
473No
0.89 (0.80-0.94)0.58 (0.48-0.68)0.65 (0.56-0.74)0.86 (0.75-0.93).47Social phobia
3549Yes
668No
0.99 (0.94-1.00)0.17 (0.01-0.27)0.62 (0.54-0.70)0.92 (0.65-0.99).18PTSD
5511Yes
911No
0.97 (0.93-0.99)0.28 (0.17-0.44)0.81 (0.73-0.86)0.79 (0.52-0.92).33OCD
2811Yes
1163No
0.98 (0.88-1.00)0.38 (0.29-0.37)0.38 (0.29-0.47)0.98 (0.88-1.00).24MDD
7143Yes
431No
0.98 (0.90-1.00)0.33 (0.25-0.42)0.42 (0.33-0.51)0.97 (0.86-1.00).23Insomnia
7135Yes
511No
0.97 (0.92-0.99)0.31 (0.17-0.50)0.88 (0.81-0.92)0.67 (0.39-0.86).35BDD
188Yes
1284No
0.99 (0.96-1.00)0.35 (0.19-0.54)0.89 (0.82-0.93)0.90 (0.60-0.98).45Bulimia nervosa
179Yes
1311No
0.99 (0.96-1.00)0.19 (0.09-0.36)0.83 (0.77-0.89)0.86 (0.49-0.97).26Alcohol dependence
256Yes
1261No
a All kappa values P<.001.
Test-Retest Reliability
Of the 60 participants who repeated the e-PASS, 39 did so within
25 days of initial completion (mean 7.98, SD 6.63) and were
included in reliability analyses. Participants received a mean
5.05 (SD 2.83) and 4.70 (SD 2.65) subclinical or clinical
diagnoses on their first and second administration, respectively,
and the difference was not significant (t38=1.56, P=.13).
Table 4 presents the cross-tabulation of e-PASS clinical
diagnoses between initial completion and retesting, as well as
the significance level of the McNemar test, the percentage
agreement, and the kappa agreement coefficient. Due to the
small sample size, the exact binomial probability of the data
was used to calculate the McNemar test [30]. This was not
significant (P>.05) for all disorders considered, indicating a
similar likelihood of change from nonclinical to clinical
diagnosis and vice versa between testing and retesting results.
However, this could also be a result of an underpowered
McNemar test given that the sample size was only n=39.
All kappa values were significant and reflected generally strong
diagnostic agreement between test and retest. Kappa was
particularly high for bulimia nervosa and panic disorder, each
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of which was associated with more than 90% agreement. There
was less agreement for insomnia, MDD, and specific phobia,
although kappa values were still considered moderate to
substantial. An inspection of cases with disagreement found
that most involved a change from a subclinical/clinical to
clinical/subclinical (respectively) result. For example, 4 of 5
cases of disagreement for specific phobia included a change
from a clinical to subclinical diagnosis, whereas the remaining
case was of a change from neither a subclinical or clinical
diagnosis to a clinical diagnosis of specific phobia.
Table 4. Test-retest reliability of e-PASS clinical diagnoses (n=39).
κbP aAgreement, %Retest, nTest
NoYes
.83.5094.9Panic disorder
26Yes
310No
.71.5087.1Social phobia
210Yes
243No
.67.2284.6GAD
511Yes
221No
.54.2287.2Specific phobia
44Yes
301No
.61.6389.8PTSD
34Yes
311No
.57.7378.5MDD
511Yes
203No
.87>.9997.4Bulimia nervosa
110Yes
271No
.60.2284.6BDD
57Yes
261No
.53>.9977.0Insomnia
412Yes
185No
a McNemar test P values.
b All kappa values significant at P<.001.
Discussion
The e-PASS is a free, internationally available, online diagnostic
assessment (and referral) program for numerous mental
disorders. As with any diagnostic tool, particularly one that is
highly accessible and can be independently undertaken, there
is a need to ensure the e-PASS is valid and reliable. Hence, this
study evaluated the psychometric properties of the e-PASS,
focusing on its diagnostic criterion validity and test-retest
reliability. To enhance the ecological validity of the study
findings, participants were recruited online and represented
prospective e-PASS users completing the program under
generally naturalistic conditions.
The e-PASS was found to have mixed diagnostic agreement
with the semistructured clinical interview (ie, the gold standard),
varying from fair (eg, OCD) to substantial (eg, panic disorder)
agreement. Compared to previously evaluated programs, the
e-PASS’ diagnostic sensitivity generally exceeded some (eg,
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Internet-administered CIDI-Short Form [12]), but not other
programs (eg, WB-DAT [9], WSQ [10]). In contrast, the
e-PASS’ specificity was generally high, resulting in far less
false-positive results than certain programs (eg, WSQ [10]).
Predictive statistics suggest that a positive e-PASS result had
at least a 45% probability of accurately reflecting an actual
disorder, whereas a negative e-PASS result for most disorders
was correct in more than 90% of cases. The latter suggests a
general strength of the e-PASS is its ability to rule out a disorder,
which could be beneficial in minimizing burden associated with
false-positive clinical diagnoses (eg, stigma, unnecessary
follow-up assessment, and treatment).
Among previously reported programs, the e-PASS most closely
resembles the WB-DAT [9]. When considering mutual disorders,
the e-PASS produced similar psychometrics to the WB-DAT,
except in the cases of OCD and PTSD, where the e-PASS
clinical result was noticeably less sensitive. It is worth
remembering that psychometric results of the WB-DAT [9]
were based on a sample recruited from a face-to-face clinic
population consisting of generally lower diagnostic base rates
compared to those seen in this study. Furthermore, the e-PASS
assesses a wider range of disorders than the WB-DAT and most
other programs. To the best of the authors’ knowledge, this is
the first study that has reported the psychometric performance
of an online program that identifies BDD and bulimia nervosa.
Although the e-PASS screens particularly well for certain
disorders (eg, panic disorder, MDD), it seems lacking for others
(eg, OCD) when considering the combination of low sensitivity
and diagnostic agreement with the clinical interview. Various
factors could help explain these mixed classification statistics
(eg, imprecise wording of some e-PASS items or unreliable
diagnostic criteria for certain disorders). Given that e-PASS
specificity often exceeded sensitivity values, one likely
explanation is that the e-PASS’ diagnostic threshold was too
high for particular disorders. In support of this, additional
analyses found that sensitivity values consistently improved
and exceeded 90% for some disorders (while maintaining
reasonable specificity) when considering an e-PASS
“subclinical” or “clinical” result as predictive of an actual
clinical disorder. This suggests that the majority of actual clinical
disorder cases at least received an e-PASS diagnosis of
subclinical, if not clinical severity, which provides some
reassurance in terms of notifying e-PASS users of potential
mental health issues. Furthermore, the e-PASS is designed so
that a subclinical result also prompts access to associated online
treatment programs or recommendations of further assessment
(eg, face-to-face consultation with a health professional) for
follow-up.
Nevertheless, the results of this study suggest one way of
improving the e-PASS’ screening properties in terms of
maximizing sensitivity would be to reduce the diagnostic
threshold (eg, so that a subclinical result is identified as a clinical
disorder). However, this in turn would increase false-positive
results, decreasing specificity. The extent to which diagnostic
thresholds should be reduced will depend on the impact on the
respective sensitivity and specificity properties, determined
using receiver operating characteristic (ROC) analyses (D
Nguyen, unpublished PhD thesis, Victoria: Swinburne
University, 2013). A further consideration is the broader impact
of accurate/inaccurate results (eg, potential burden of diagnosis
including financial costs, stigma, and access of ineffective
treatment) which further contributes to the overall utility of the
e-PASS.
The e-PASS also demonstrates strong test-retest reliability for
identifying a clinical disorder (particularly for panic disorder
and bulimia nervosa) over an average of approximately 1 week
and a maximum of 25 days. Compared to the ISP-D online
screener for MDD [11], the e-PASS produced comparable
consistency in identifying MDD. The results of this study are
the first to document the test-retest reliability of an online
diagnostic assessment program for the other reported disorders
(eg, anxiety disorders, insomnia, bulimia nervosa). In general,
the e-PASS’ test-retest reliability measures are comparable to
those of a computer-assisted administration of the CIDI [31]
and a clinician-administered MINI [32].
In this study, the few e-PASS cases with test-retest discrepancies
were just as likely to reflect a diagnostic change from clinical
to nonclinical compared with nonclinical to clinical. However,
this result may have stemmed from underpowered statistical
testing given the smaller than expected sample size. On closer
inspection, test-retest discrepancies were generally subtle and
tended to involve changes from clinical to subclinical results
(and vice versa). This may have reflected actual symptom
changes given the instability of certain disorders (eg, MDD)
over the retesting period of up to 25 days after initial completion.
Unfortunately, the reliability sample was too small to limit the
analysis to those with shorter test-retest intervals (eg, 1 week).
Overall, e-PASS results appear to be generally stable over the
short term, which suggests that the potential variability of the
online experience does not pose a significant risk to test-retest
reliability.
Several limitations should be considered when interpreting the
current findings. Firstly, insufficient clinical interviews were
recorded to analyze interrater reliability. Also, the administration
order of the e-PASS and clinical interview was not
counterbalanced and participants’ viewing of e-PASS results
in particular may have biased subsequent interview responses.
The period between e-PASS and clinical interview completion
(mean approximately 10 days) as well as between test and retest
of the e-PASS (mean approximately 8 days) may have led to
actual symptom changes in some cases. Therefore, the reported
validity and reliability statistics could be conservative estimates.
Furthermore, the limited number of participants repeating the
e-PASS prompts the need for further reliability testing with a
larger sample, while also possibly indicating that the e-PASS
has low acceptability to some users. Indeed, separate research
(D Nguyen, unpublished PhD thesis, Victoria: Swinburne
University, 2013) has suggested that some of the e-PASS users
were deterred from further use due to certain factors (eg, length,
perceived repetition, lack of immediate assistance and support).
Participant recruitment targeted prospective e-PASS users to
enhance the ecological validity of findings. Although not
reported in this study, the sociodemographic characteristics (eg,
gender, employment and marital status, education level) of the
approximately 13,000 individuals who completed the e-PASS
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between October 2009 and October 2012 largely resemble those
of this study sample. Nevertheless, the extent to which results
based on this study’s sample can be generalized to all e-PASS
users requires a more detailed analysis of participant
characteristics as well as their potential relationship with
psychometric properties. For example, it may be that certain
individual characteristics (eg, education level) could be more
conducive for e-PASS diagnostic validity or reliability.
With the introduction of DSM-5 [33], there is a need to revise
the e-PASS in-line with new criteria and reevaluate its
psychometric properties. Program changes will be minor for
most disorder modules (eg, for MDD), although some will
require substantial changes (eg, PTSD). Interestingly, the best
performing e-PASS diagnoses (eg, MDD and panic disorder)
are also those with relatively little criteria change from
DSM-IV-TR to DSM-5. The e-PASS targets 21 disorders, but
many of these (eg, anorexia nervosa, pathological gambling,
substance disorders) were not examined due to very low
diagnostic base rates in the sample. Therefore, further evaluation
could involve specific population groups to clarify the e-PASS
psychometric properties for these disorders. Additional
psychometric evaluation could also consider properties such as
the internal reliability of individual e-PASS items, although this
would require a much larger sample size as well as modifications
to the e-PASS form (eg, removing branching rules) to provide
a suitable dataset for analysis.
New means of online diagnostic screening raises the issue of
whether to replace, adapt, or supplement Internet-based
programs such as the e-PASS. There is potential, for example,
to incorporate audiovisual content (eg, [34]) that could enhance
accessibility and acceptability. In light of its mixed diagnostic
performance, Internet-based screening could also be followed
up with clinician interviewing via videoconferencing (eg,
[35,36]) or Web chat (eg, [37,38]). Online assessment could
also be complemented with mobile-based applications measuring
in-the-moment symptoms via questionnaires [39] or audiovisual
cues (eg, speech and body language) of the respondent [40].
In contrast to diagnostic screeners, the use of online clinical
scales focusing on dimensional measures may prove to offer
greater utility in the assessment of mental health disorders [41].
Such programs extend beyond Internet administrations of
standard paper-and-pencil measures and are becoming
increasingly sophisticated. For example, Batterham et al [42]
proposed a hierarchical system commencing with brief online
prescreening (eg, K6) followed by an administration of relevant
disorder-specific scales. Computer adaptive testing based on
item response theory also shows promise in terms of efficiently
screening latent traits underlying mental disorders (eg, [43,44]).
In the meantime, given the utility of a diagnosis in clinical
practice [1], there is still arguable value in offering
Internet-based questionnaires that produce diagnostic results
and directly query diagnostic criteria as similar to the approach
of gold standard structured clinical interview schedules [5]. As
this study shows, an Internet-based diagnostic assessment
program can produce diagnostic results that have high test-retest
reliability and, at least for certain disorders, high criterion
validity. Despite their potential psychometric limitations, these
programs could be incorporated into traditional clinical practice
alongside other imperfect assessment means (eg, unstructured
interviewing) to broaden assessment information and improve
overall diagnostic accuracy [3,5]. For many consumers who are
unable or unwilling to access traditional services, Internet-based
programs could offer a “good enough” alternative for identifying
mental health disorders.
In conclusion, this study suggests that the e-PASS has potential
for assisting in the diagnosis of mental health disorders and, in
doing so, facilitating access to appropriate interventions among
other benefits of identifying mental disorders. Nevertheless,
further development and evaluation is needed to clarify the full
scope of its clinical utility.
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